PHAXIAM Therapeutics S.A. (PHXM) — Working Capital to Net Assets Ratio
PHAXIAM Therapeutics S.A. (PHXM) has a Working Capital to Net Assets ratio of -62.3% as of June 2024. Working capital of €-9.62 Million (current assets of €5.89 Million minus current liabilities of €15.51 Million) is measured against net assets of €15.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PHXM defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PHAXIAM Therapeutics S.A. Working Capital to Net Assets (2012–2023)
This chart shows how PHAXIAM Therapeutics S.A.'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2023. As of June 2024, the ratio stands at -62.3%, reflecting working capital of €-9.62 Million against net assets of €15.45 Million EUR. For the complete balance sheet picture, see PHAXIAM Therapeutics S.A. assets under control.
Annual Working Capital to Net Assets for PHAXIAM Therapeutics S.A. (2012–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for PHAXIAM Therapeutics S.A. from 2012 to 2023, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PHAXIAM Therapeutics S.A. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 3.7% | €955.00K | €25.61 Million | €16.22 Million | €15.26 Million | ▼ -128.1 pp |
| 2022 | 131.8% | €30.96 Million | €23.49 Million | €42.63 Million | €11.68 Million | ▲ +44.1 pp |
| 2021 | 87.7% | €20.04 Million | €22.84 Million | €40.05 Million | €20.00 Million | ▲ +11.3 pp |
| 2020 | 76.4% | €20.29 Million | €26.54 Million | €49.63 Million | €29.35 Million | ▲ +4.3 pp |
| 2019 | 72.1% | €61.70 Million | €85.56 Million | €81.58 Million | €19.88 Million | ▼ -16.7 pp |
| 2018 | 88.8% | €129.26 Million | €145.60 Million | €149.91 Million | €20.65 Million | ▼ -10.4 pp |
| 2017 | 99.2% | €179.96 Million | €181.42 Million | €191.57 Million | €11.61 Million | ▼ -2.3 pp |
| 2016 | 101.5% | €36.19 Million | €35.64 Million | €42.53 Million | €6.35 Million | ▲ +3.3 pp |
| 2015 | 98.3% | €46.31 Million | €47.13 Million | €51.93 Million | €5.62 Million | ▼ -0.2 pp |
| 2014 | 98.4% | €35.27 Million | €35.82 Million | €39.53 Million | €4.26 Million | ▼ -1.1 pp |
| 2013 | 99.5% | €13.52 Million | €13.59 Million | €17.04 Million | €3.51 Million | ▲ +140.8 pp |
| 2012 | -41.3% | €1.66 Million | €-4.03 Million | €9.14 Million | €7.48 Million | — |